ABS-15 is a novel treatment for Crohn's Disease. It is a single molecule with mutual pro-drugs of individual drugs that are well known and have an excellent safety record. The unique combination can provide a topical anti-inflammatory effect to the lower intestinal track and colonic tissue during an outbreak. Administration of this non-absorbed salt form of well known analgesic will provide a synergistic effect through a combination of anti-inflammatory, antimicrobial and antidiarrheal effects in the local area.